Heart Metabolics Ltd.
Wednesday, 30 April 2014![](/assets/components/images/ourExperience/news_1415028694_9963.jpg)
Acted as Irish counsel for Heart Metabolics Limited, a new Irish biotechnology company focused on the development of drugs for cardio-metabolic diseases, in relation to the completion of a $20 million Series A financing from venBio, Seroba Kernel Life Sciences, AustralianSuper and AshHill.